Ledger.Open graph →
SEC Form D · filed April 11, 2024

Nucleus Radiopharma, Inc

Offering
$6.0M
Sold
$6.0M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
PALO ALTO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Norman Sharpless · Palo Alto, CADirectorManu Nair · Palo Alto, CADirectorChris Mcdonald · Palo Alto, CADirectorTyrell Rivers · Palo Alto, CADirectorCharles Conroy · Palo Alto, CAExec · DirectorMary Kate Wold · Palo Alto, CADirectorMichael Rossi · Palo Alto, CADirectorJustin Butler · Palo Alto, CADirectorChris Mcdonald · Palo Alto, CADirectorMary Kate Wold · Palo Alto, CADirectorTyrell Rivers · Palo Alto, CADirectorCharles Conroy · Palo Alto, CAExec · DirectorManu Nair · Palo Alto, CADirectorMichael Rossi · Palo Alto, CADirectorNorman Sharpless · Palo Alto, CADirectorJustin Butler · Palo Alto, CADirectorGwendoline Licata · Luxembourg, LuxembourgDirectorMitchell R. Julis · Dallas, TXDirectorJoshua S. Friedman · Dallas, TXDirectorLvna Capital LLC · CORAL GABLES, FLDirectorLvna Management LLC · CORAL GABLES, FLDirectorKevin S. Rohnstock · Denver, CODirectorTony S. Argibay · Denver, CODirectorMichael S. Mohapp · Denver, COExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗